Class of diabetes medication associated with lower incidence of Parkinson's disease
A class of drugs used to treat diabetes may be associated with protection against Parkinson's disease (PD), according to research published this week in PLOS Medicine. The study, conducted by Dr. Ruth Brauer, of the London School of Hygiene & Tropical Medicine, found a lower incidence of PD among people using a glitazone drug (either rosiglitazone or pioglitazone) to treat diabetes when compared to people who had used different treatments for diabetes.
The cohort study was conducted using data from the UK Clinical Practice Research Datalink, and compared individuals with ...



